https://qilindo.com/wp-content/uploads/2021/08/Approved-Pulsewave-explainer-video-1.mp4

Pulsewave AG

Health Monitoring

Play Video
Play Video

Video

Presentation

One Pager

Favorites

Raising

$1,500,000

in exchange for

15%

Industry

Medical

Company Size

2-5

Patent

Pending

Location

Israel

Languages

English, Hebrew

Website URL​

A discreet monitoring device fixed on any eyeglasses frame that collects vital information, processes it via deep learning algorithms, and makes it available for doctors before CVD events can occur.

  • All day
  • Real-time
  • Long term
  • AI supported
  • Pre/Post event

Either slide & clip on, or have an Optician replace the temple ends with TempleGuard.

The Vision

Make vital information available to doctors before CVD events occur.

The Product

“TempleGuard” is a wearable device that attaches to eyeglasses and measures vital signs from behind the ear. The device combines real-time patient monitoring with AI algorithms in order to predict the development of CVD (Cardio-Vascular Disease).

Two extensive rounds of IP research with the Swiss Federal Institute of Intellectual Property showed no existing relative patents.

 

We filed a full US Patent Application (No. 17/109,934) on Dec. 2nd, 2020.

Overview

A discreet monitoring device fixed on any eyeglasses frame that collects vital information, processes it via deep learning algorithms, and makes it available for doctors before CVD events can occur.

  • All day
  • Real-time
  • Long term
  • AI supported
  • Pre/Post event

Either slide & clip on, or have an Optician replace the temple ends with TempleGuard.

The Vision

Make vital information available to doctors before CVD events occur.

The Product

“TempleGuard” is a wearable device that attaches to eyeglasses and measures vital signs from behind the ear. The device combines real-time patient monitoring with AI algorithms in order to predict the development of CVD (Cardio-Vascular Disease).

Two extensive rounds of IP research with the Swiss Federal Institute of Intellectual Property showed no existing relative patents.

 

We filed a full US Patent Application (No. 17/109,934) on Dec. 2nd, 2020.

The Team

Please Sign In or Register to view this content.

The Market

Please Sign In or Register to view this content.

Problem & Solution

17.9 million people died from CVD in 2018, representing 31% of all global deaths. 

30% of CVD monitoring devices are abandoned within 6–12 months, mainly due to inconvenience.

Our product ‘TempleGuard’ will solve the problem of a convenient & discreet vital sign monitor, which is small and capable enough to collect cardiac indicators that are associated with blood pressure and arterial stiffness in real-time, throughout the day and over the course of years.

Please Sign In or Register to view this content.

A D D M Y S T A R T U P

Get Full Access

We need to know you better

Before we approve and open the option to send messages to all the startups, we need to know you better. please fill out the form:

Want to See More?

Sign up as an investor or add your startup to gain full access.
It’s absolutely free!

Don't Miss An Opportunity

Sign up as a investor and gain full access. It’s absolutely free!

New Report

Close